Daewoong Pharmaceutical Co., Ltd

069620.KS · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

53,424 KRW (≈ 37.40 USD)

Margin of Safety

-129.9 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Daewoong Pharmaceutical is a South Korean specialty and generic pharmaceutical manufacturer that generates revenues from the distribution of proprietary and licensed products, the export of botulinum toxin products (Nabota), as well as from a growing pipeline of innovative active substances.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.